Arya Probio Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-01-2025
- Paid Up Capital ₹ 0.10 M
as on 09-01-2025
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 22.78%
(FY 2020)
- Profit -54.65%
(FY 2020)
- Ebitda -134.99%
(FY 2020)
- Net Worth -44.56%
(FY 2020)
- Total Assets 21.72%
(FY 2020)
About Arya Probio
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mukund Kulkarni, Priyanka Mukund, and Tejas Kulkarni serve as directors at the Company.
- CIN/LLPIN
U74900MH2012PTC229220
- Company No.
229220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arya Probio?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejas Kulkarni  | Managing Director | 02-Mar-2020 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyanka Mukund | Director | 10-Aug-2012 | Current |
| Mukund Kulkarni | Director | 04-Apr-2012 | Current |
Financial Performance of Arya Probio.
Arya Probio Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 22.78% increase. The company also saw a substantial fall in profitability, with a 54.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arya Probio?
In 2017, Arya Probio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ajanta Beverages Private LimitedActive 14 years 1 monthMukund Kulkarni and Priyanka Mukund are mutual person
- Ecologic Research FoundationActive 8 years 4 days
Mukund Kulkarni, Priyanka Mukund and 1 more are mutual person
- Avishi Biosciences Private LimitedActive 8 years 11 months
Mukund Kulkarni, Priyanka Mukund and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arya Probio?
Unlock and access historical data on people associated with Arya Probio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arya Probio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arya Probio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
